MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590'. Together they form a unique fingerprint.

Medicine & Life Sciences